What does US20110105418 cover about heparin?
US20110105418 is a U.S. patent application related to heparin, but the provided information doesn’t include the application’s title, abstract, claims, or the specific technical details. Without those text excerpts, I can’t accurately describe what it covers (for example, whether it’s about purification, chemical modification, formulation, dosing, anticoagulant activity, detection/assay methods, or manufacturing).
How can I identify the exact heparin-related invention in US20110105418?
To pinpoint the invention, the fastest route is to look at the application’s:
- Title (usually tells you the general area)
- Abstract (summarizes the core idea)
- Independent claims (defines what is legally claimed)
- Background/summary sections (often explain the problem the invention solves)
If you paste the abstract or one independent claim here, I can translate it into plain English and summarize what’s novel and how it’s different from existing heparin methods.
Is there an associated branded drug or commercial product using this heparin patent?
Heparin-related patents are often about manufacturing or downstream processing rather than a specific branded “drug,” so whether US20110105418 maps to a marketed product depends on how it’s drafted (process vs. therapeutic composition vs. assay/lab use).
If you share the patent’s assignee/company name from the record, I can help connect it to the likely commercial context (for example, specific heparin suppliers or product lines).
Where can I find reliable details for US20110105418?
You can typically get the authoritative text (title, abstract, claims, assignee, priority dates) from USPTO or patent databases. DrugPatentWatch.com can sometimes help with patent linkage and status signals when the heparin patent is connected to a specific listed product or family (linking details depend on how the listing is organized) [1].
If you tell me what site you’re using (or paste the abstract), I can make a precise, claim-level summary.
What I need from you to answer precisely
Reply with any one of the following and I’ll produce an accurate heparin-focused summary of US20110105418:
- the title + abstract, or
- screenshots/text of the independent claims, or
- the assignee and priority date shown on the record.
Sources
[1] https://www.drugpatentwatch.com/